Dr. Öğr. Üyesi GÖZDE YENİCE ÇAKMAK

Yayın Ağı

Makaleler 3

1. Some novel benzimidazole and benzoxazole methyl ester derivatives as BCL2 inhibitors and BAX activators: Synthesis, anticancer activity and in silico evaluation

Yenice Çakmak G., Erzurumlu Y., Ozguven S. Y., Yildiz I.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY , cilt.318, 2026 (SCI-Expanded, Scopus)

2. Antitumor activity against human promyelocytic leukemia and in silico studies of some benzoxazines

Oksuzoglu E., Yilmaz S., YENİCE ÇAKMAK G., Ataei S., YILDIZ İ.

Journal of Biomolecular Structure and Dynamics , cilt.41, sa.17, ss.8175-8190, 2023 (SCI-Expanded, Scopus)

3. TREATMENT OF BEHÇET’S DISEASE AND CURRENT APPROACHES BEHÇET HASTALIĞININ TEDAVİSİ VE GÜNCEL YAKLAŞIMLAR

YENİCE ÇAKMAK G., Şehirli A. Ö.

Ankara Universitesi Eczacilik Fakultesi Dergisi , cilt.46, sa.2, ss.619-650, 2022 (Scopus, TRDizin)

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 13

1. SOME NOVEL BENZIMIDAZOLE DERIVATIVES AS BAX ACTIVATORS: SYNTHESIS, ANTICANCER ACTIVITY AND IN SILICO EVALUATION

YENİCE ÇAKMAK G., ERZURUMLU Y., YILMAZ ÖZGÜVEN S., YILDIZ İ.

25th European Symposium on Quantative Structure-Activity Relationship (25th EUROQSAR), Perugia, İtalya, 27 Eylül - 01 Ekim 2026, (Özet Bildiri)

2. In Silico Anticancer Activity Studies of Some Benzoxazine Derivatives As Potential Htopo IIα Inhibitors. PP-095; p 193.

YENİCE ÇAKMAK G., YILMAZ ÖZGÜVEN S., YILDIZ İ.

23nd European Symposium on Quantitative Structure-Activity Relationships Translational and Health Informatics (EuroQSAR), Heidelberg, Almanya, 26 Eylül 2022, (Özet Bildiri)

3. IN SILICO ANTICANCER ACTIVITY STUDIES OF SOME BENZOXAZINE DERIVATIVES AS POTENTIAL hTopo IIa INHIBITORS

YENİCE ÇAKMAK G., ÖKSÜZOĞLU E., YILMAZ ÖZGÜVEN S., Ataei S., YILDIZ İ.

Euroqsar2022 23rd European on Quantitative Structure-Activity Relationship Integrative Data-Intensive Approaches to Drug Design, Heidelberg, Almanya, 26 - 30 Eylül 2022, (Özet Bildiri)

4. Benzazol Türevi Bazı Yeni Bileşiklerin Sentezi, Antikanser Aktivitelerinin İncelenmesi ve Moleküler Modelleme Çalışmaları. P95, SS 211-222

YENİCE ÇAKMAK G., YILMAZ ÖZGÜVEN S.

VI. Ulusal Farmasötik Kimya Kongresi, İstanbul, Türkiye, 26 Ağustos 2022, (Özet Bildiri)

5. MOLECULAR DOKING STUDIES OF SOME COX-2 INHIBITORS ON AChE ENZYME

KAHVECIOGLU D., YENİCE ÇAKMAK G., YILMAZ ÖZGÜVEN S.

INTERNATIONAL CONGRESS OF MULTIDISCIPLINARY STUDIES IN HEALTH SCIENCES, Erzurum, Türkiye, 18 Şubat 2022, (Tam Metin Bildiri)

6. SYNTHESIS AND MOLECULAR MODELING STUDIES OF SOME NOVEL BENZOTHIAZOLE DERIVATIVES AS ANTI-CANCER AGENTS

YENİCE ÇAKMAK G., YILMAZ S., YILDIZ İ.

13th International Symposium on Pharmaceutical Sciences (ISOPS), Ankara, Türkiye, 22 - 25 Haziran 2021, (Özet Bildiri) Sürdürülebilir Kalkınma

7. Synthesis, and Molecular Docking Studies of Some Novel Benzothiazoles as HDAC Inhibitors

YENİCE ÇAKMAK G., YILMAZ S.

8. İlaç Kimyası Kongresi, Antalya, Türkiye, 27 - 29 Şubat 2020, (Özet Bildiri)

8. Molecular Modelling Studies Of Some Designed Benzothiazole Derivatives As K-Ras(G12C) Inhibitors

YENİCE G., YILMAZ S.

10th International Symposium on Computational Methods in Toxicology and Pharmacology Integrating Internet Resources, Ioannina, Yunanistan, 23 - 27 Haziran 2019, (Özet Bildiri)

9. Investigation of Molecular Interactions Between KRAS G12C and Known Anticancer Agents Influential in Lung Cancer, P-36: p146.

YENİCE G., YILMAZ S.

6th International BAU Drug Design Congress, İstanbul, Türkiye, 13 - 15 Aralık 2018, (Özet Bildiri) Sürdürülebilir Kalkınma

10. Investigation of Molecular Interaction Dynamics Between RAS and KRAS(G12C) Inhibitors. PP-14: p69.

YENİCE G., YILMAZ S.

’5th International Conference on Computation for Science and Technology (ICCST), Antalya, Türkiye, 23 - 26 Eylül 2018, (Özet Bildiri)

11. Molecular Docking Studies on K-RAS(G12C) with Known Anticancer Agents Used in the Treatment of Lung Cancer. PP-119: p315.

YENİCE G., YILMAZ S.

22nd European Symposium on Quantitative Structure-Activity Relationships (22nd EuroQSAR), Selanik, Yunanistan, 16 - 20 Eylül 2018, (Özet Bildiri) Sürdürülebilir Kalkınma